137 related articles for article (PubMed ID: 25337130)
41. Comparison of IPSA and HIPO inverse planning optimization algorithms for prostate HDR brachytherapy.
Panettieri V; Smith RL; Mason NJ; Millar JL
J Appl Clin Med Phys; 2014 Nov; 15(6):5055. PubMed ID: 25493531
[TBL] [Abstract][Full Text] [Related]
42. Accuracy of an in vivo dosimetry-based source tracking method for afterloading brachytherapy - A phantom study.
Jørgensen EB; Kertzscher G; Buus S; Bentzen L; Hokland SB; Rylander S; Tanderup K; Johansen JG
Med Phys; 2021 May; 48(5):2614-2623. PubMed ID: 33655555
[TBL] [Abstract][Full Text] [Related]
43. Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants.
Kini VR; Edmundson GK; Vicini FA; Jaffray DA; Gustafson G; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):571-8. PubMed ID: 10078639
[TBL] [Abstract][Full Text] [Related]
44. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability.
Stroom JC; de Boer HC; Huizenga H; Visser AG
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):905-19. PubMed ID: 10098447
[TBL] [Abstract][Full Text] [Related]
45. Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapy.
Nicolae A; Murgic J; Kruljac I; Dubnitzky L; D'Alimonte L; Lu L; Cumal A; Law N; Morton G; Loblaw A; Chung HT; Ravi A
Brachytherapy; 2018; 17(2):306-312. PubMed ID: 29239812
[TBL] [Abstract][Full Text] [Related]
46. Interobserver variations of target volume delineation and its impact on irradiated volume in accelerated partial breast irradiation with intraoperative interstitial breast implant.
Upreti RR; Budrukkar A; Wadasadawala T; Misra S; Gurram L; Pathak R; Deshpande DD
J Contemp Brachytherapy; 2017 Apr; 9(2):139-145. PubMed ID: 28533802
[TBL] [Abstract][Full Text] [Related]
47. The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer.
Yoshioka Y; Yoshida K; Yamazaki H; Nonomura N; Ogawa K
J Radiat Res; 2013 Sep; 54(5):781-8. PubMed ID: 23543798
[TBL] [Abstract][Full Text] [Related]
48. High-dose-rate prostate brachytherapy based on registered transrectal ultrasound and in-room cone-beam CT images.
Even AJ; Nuver TT; Westendorp H; Hoekstra CJ; Slump CH; Minken AW
Brachytherapy; 2014; 13(2):128-36. PubMed ID: 24041955
[TBL] [Abstract][Full Text] [Related]
49. Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial.
Martinez A; Gonzalez J; Stromberg J; Edmundson G; Plunkett M; Gustafson G; Brown D; Yan D; Vicini F; Brabbins D
Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1019-27. PubMed ID: 7493828
[TBL] [Abstract][Full Text] [Related]
50. A comparison of treatment planning techniques for low-dose-rate (LDR) prostate brachytherapy.
Connolly D; Sands G; Winter H; Foley MJ; Kleefeld C
Brachytherapy; 2021; 20(2):410-419. PubMed ID: 33234407
[TBL] [Abstract][Full Text] [Related]
51. A comparison between tandem and ovoids and interstitial gynecologic template brachytherapy dosimetry using a hypothetical computer model.
Hsu IC; Speight J; Hai J; Vigneault E; Phillips T; Pouliot J
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):538-43. PubMed ID: 11872302
[TBL] [Abstract][Full Text] [Related]
52. BrachyView, a novel inbody imaging system for HDR prostate brachytherapy: design and Monte Carlo feasibility study.
Safavi-Naeini M; Han Z; Cutajar D; Guatelli S; Petasecca M; Lerch ML; Franklin DR; Jakubek J; Pospisil S; Bucci J; Zaider M; Rosenfeld AB
Med Phys; 2013 Jul; 40(7):071715. PubMed ID: 23822419
[TBL] [Abstract][Full Text] [Related]
53. Influence of source batch S dispersion on dosimetry for prostate cancer treatment with permanent implants.
Nuñez-Cumplido E; Perez-Calatayud J; Casares-Magaz O; Hernandez-Armas J
Med Phys; 2015 Aug; 42(8):4933-40. PubMed ID: 26233219
[TBL] [Abstract][Full Text] [Related]
54. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis.
Weitmann HD; Pötter R; Waldhäusl C; Nechvile E; Kirisits C; Knocke TH
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):468-78. PubMed ID: 15890589
[TBL] [Abstract][Full Text] [Related]
55. Optimization of dose distribution for HDR brachytherapy of the prostate using Attraction-Repulsion Model.
Sumida I; Shiomi H; Yoshioka Y; Inoue T; Lessard E; Hsu IC; Pouliot J
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):643-9. PubMed ID: 16289907
[TBL] [Abstract][Full Text] [Related]
56. Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants.
Haworth A; Ebert M; St Clair S; Carey BM; Flynn A; Bottomley DM; Duchesne GM; Joseph D; Ash D
Brachytherapy; 2005; 4(2):146-53. PubMed ID: 15893269
[TBL] [Abstract][Full Text] [Related]
57. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
58. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
D'Souza WD; Thames HD; Kuban DA
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1540-8. PubMed ID: 15050335
[TBL] [Abstract][Full Text] [Related]
59. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer.
Wazer DE; Lowther D; Boyle T; Ulin K; Neuschatz A; Ruthazer R; DiPetrillo TA
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):107-11. PubMed ID: 11316552
[TBL] [Abstract][Full Text] [Related]
60. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
